Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis

ClinicalTrials.gov ID: NCT03816891

Public ClinicalTrials.gov record NCT03816891. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 2:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a/b, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of KPL-716 in Reducing Pruritus in Subjects With Prurigo Nodularis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study of the efficacy, safety, tolerability, pharmacokinetics (PK), and immunogenicity of Vixarelimab (KPL-716) in subjects with prurigo nodularis (PN).

Study identification

NCT ID
NCT03816891
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genentech, Inc.
Industry
Enrollment
240 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 11, 2019 (Actual)
Primary completion
Dec 28, 2022 (Actual)
Completion
Aug 24, 2023 (Actual)
Last update posted
Jan 13, 2026

2019 – 2023

United States locations

U.S. sites
40
U.S. states
19
U.S. cities
36
Facility City State ZIP Site status
Arizona Research Center Phoenix Arizona 85053 —
Investigate MD, LLC Scottsdale Arizona 85255 —
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
First OC Dermatology Fountain Valley California 92708 —
Center for Dermatology Clinical Research, Inc. Fremont California 94538 —
Dermatology Research Associates Los Angeles California 90045 —
Wallace Medical Group, Inc. Los Angeles California 90056 —
Velocity Clinical Research - North Hollywood North Hollywood California 91606 —
Colorado Center for Dermatology, PLLC Centennial Colorado 80111 —
George Washington University Medical Faculty Associates Washington D.C. District of Columbia 20037 —
Rybear, Inc. Fort Lauderdale Florida 33316 —
University of Florida, Department of Dermatology Gainesville Florida 32610 —
Olympian Clinical Research Largo Florida 33770 —
University of Miami Itch Center Miami Florida 33136 —
Riverchase Dermatology Pembroke Pines Florida 33028 —
Olympian Clinical Research St. Petersburg Florida 33709 —
Advanced Clinical Research Institute Tampa Florida 33607 —
Palm Harbor Dermatology Tampa Florida 33609 —
Olympian Clinical Research Tampa Florida 33614 —
Alliance Clinical Research of Tampa Tampa Florida 33615 —
Integrated Clinical Research West Palm Beach Florida 33406 —
Advanced Medical Research PC Sandy Springs Georgia 30328 —
DS Research New Albany Indiana 47150 —
DS Research Louisville Kentucky 40241 —
ALLCUTIS Research, LLC Beverly Massachusetts 01915 —
ActivMed Practices & Research, Inc. Methuen Massachusetts 01844 —
Michigan Center for Skin Care Research Clinton Township Michigan 48038 —
Hamzavi Dermatology Fort Gratiot Michigan 48059 —
Somerset Skin Centre Troy Michigan 48084 —
Grekin Skin Institute Warren Michigan 08088 —
Skin Specialists, PC Omaha Nebraska 68144 —
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756 —
Bobby Buka MD, PC New York New York 10012 —
University of Rochester Dermatology at College Town Rochester New York 14620 —
Wright State Physicians Fairborn Ohio 45324 —
Paddington Testing Co., Inc. Philadelphia Pennsylvania 19103 —
Medical University of South Carolina, Department of Dermatology and Dermatological Surgery Charleston South Carolina 29425 —
Austin Institute for Clinical Research, Inc. Pflugerville Texas 78660 —
Progressive Clinical Research, PA San Antonio Texas 78213 —
Dermatology Specialists of Spokane Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03816891, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 13, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03816891 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →